rTMS and Botulinum Toxin in Primary Cervical Dystonia

NACompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

June 28, 2021

Study Completion Date

June 28, 2021

Conditions
Primary Cervical DystoniaDystonia
Interventions
DEVICE

NeuroStar TMS therapy

Application of repetitious transcranial magnetic stimulation (TMS) pulses using NeuroStar device to a specific brain target at predefined stimulation parameters.

DEVICE

Sham NeuroStar TMS therapy

Same procedure as real rTMS without stimulating the cerebral cortex.

OTHER

Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS)

All participants will receive a clinical assessment of dystonia severity by using the TWSTRS test.

OTHER

Craniocervical Dystonia Questionnaire (CDQ-24)

All participants will fill out the Craniocervical Dystonia Questionnaire (CDQ-24) quality of life questionnaire.

OTHER

Cerebellar-brain Inhibition (CBI)

All participants will have a measure of the cerebellar-brain inhibition(CBI) which will be conducted by using a TMS device determining the ability of the coil to activate the cerebellum.

PROCEDURE

Botulinum toxin injections

All participants will receive Botulinum toxin(BoNT) injections as part of their standard of care

Trial Locations (2)

32607

UF Center for Movement Disorders & Neurorestoration, Gainesville

32611

UF Brain Institute, Gainesville

Sponsors
All Listed Sponsors
collaborator

American Brain Foundation

OTHER

collaborator

Neuronetics

OTHER

lead

University of Florida

OTHER

NCT02542839 - rTMS and Botulinum Toxin in Primary Cervical Dystonia | Biotech Hunter | Biotech Hunter